Concepts (62)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 7 | 2023 | 294 | 3.260 |
Why?
|
| Pancreatic Neoplasms | 5 | 2023 | 106 | 3.200 |
Why?
|
| Liposomes | 3 | 2023 | 107 | 1.550 |
Why?
|
| Antineoplastic Agents | 4 | 2023 | 756 | 1.500 |
Why?
|
| Drug Delivery Systems | 4 | 2021 | 182 | 1.430 |
Why?
|
| Fluorouracil | 3 | 2023 | 32 | 1.230 |
Why?
|
| Blood-Brain Barrier | 4 | 2021 | 153 | 1.000 |
Why?
|
| Cerebral Amyloid Angiopathy | 2 | 2014 | 17 | 0.830 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 74 | 0.760 |
Why?
|
| Brain Ischemia | 1 | 2021 | 179 | 0.710 |
Why?
|
| Stroke | 1 | 2021 | 274 | 0.650 |
Why?
|
| Contrast Media | 1 | 2017 | 95 | 0.600 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 468 | 0.600 |
Why?
|
| Colorectal Neoplasms | 1 | 2020 | 413 | 0.530 |
Why?
|
| Gadolinium | 3 | 2023 | 27 | 0.510 |
Why?
|
| Mice | 6 | 2023 | 5668 | 0.510 |
Why?
|
| Alzheimer Disease | 2 | 2013 | 881 | 0.470 |
Why?
|
| Nanostructures | 1 | 2014 | 133 | 0.430 |
Why?
|
| Animals | 8 | 2023 | 14307 | 0.430 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2023 | 242 | 0.400 |
Why?
|
| Deoxycytidine | 2 | 2023 | 21 | 0.390 |
Why?
|
| Cell Line, Tumor | 3 | 2023 | 2128 | 0.390 |
Why?
|
| Neoplasm Transplantation | 2 | 2020 | 114 | 0.350 |
Why?
|
| Amyloid | 1 | 2008 | 52 | 0.330 |
Why?
|
| Brain | 2 | 2021 | 1268 | 0.320 |
Why?
|
| Cell Proliferation | 2 | 2022 | 1149 | 0.280 |
Why?
|
| Apoptosis | 2 | 2022 | 1317 | 0.250 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2023 | 32 | 0.220 |
Why?
|
| Tissue Distribution | 1 | 2023 | 197 | 0.220 |
Why?
|
| Gene Transfer Techniques | 1 | 2021 | 43 | 0.210 |
Why?
|
| HCT116 Cells | 1 | 2020 | 34 | 0.200 |
Why?
|
| Humans | 7 | 2023 | 34853 | 0.190 |
Why?
|
| Mice, SCID | 1 | 2020 | 143 | 0.190 |
Why?
|
| Receptor, erbB-2 | 1 | 2020 | 122 | 0.180 |
Why?
|
| Cattle | 2 | 2013 | 472 | 0.180 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 1300 | 0.160 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 22 | 0.160 |
Why?
|
| Viscosity | 1 | 2017 | 37 | 0.160 |
Why?
|
| Area Under Curve | 1 | 2017 | 91 | 0.160 |
Why?
|
| Hot Temperature | 1 | 2017 | 120 | 0.150 |
Why?
|
| Particle Size | 1 | 2017 | 200 | 0.150 |
Why?
|
| Cells, Cultured | 2 | 2013 | 1442 | 0.150 |
Why?
|
| Mice, Nude | 1 | 2017 | 323 | 0.150 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 781 | 0.130 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2014 | 16 | 0.120 |
Why?
|
| Models, Biological | 1 | 2017 | 642 | 0.120 |
Why?
|
| Cyclophosphamide | 1 | 2014 | 52 | 0.120 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 72 | 0.120 |
Why?
|
| Cerebral Amyloid Angiopathy, Familial | 1 | 2013 | 3 | 0.120 |
Why?
|
| Mutant Proteins | 1 | 2013 | 48 | 0.110 |
Why?
|
| Neoplasms | 1 | 2023 | 1033 | 0.110 |
Why?
|
| Models, Neurological | 1 | 2013 | 123 | 0.110 |
Why?
|
| Protein Transport | 1 | 2013 | 286 | 0.110 |
Why?
|
| Cell Line | 1 | 2014 | 1289 | 0.090 |
Why?
|
| Endothelial Cells | 1 | 2013 | 296 | 0.090 |
Why?
|
| Inflammation | 1 | 2014 | 577 | 0.090 |
Why?
|
| Chitosan | 1 | 2008 | 36 | 0.080 |
Why?
|
| Female | 2 | 2017 | 19873 | 0.060 |
Why?
|
| Pharmacogenetics | 1 | 2023 | 45 | 0.060 |
Why?
|
| California | 1 | 2023 | 436 | 0.050 |
Why?
|
| Florida | 1 | 2023 | 358 | 0.050 |
Why?
|
| Minority Groups | 1 | 2023 | 537 | 0.040 |
Why?
|